Skip to main content
Figure 6 | BMC Cancer

Figure 6

From: Loss of Akt1 or Akt2 delays mammary tumor onset and suppresses tumor growth rate in MTB-IGFIR transgenic mice

Figure 6

Cytokeratin expression in mammary tumors from MTB-IGFIR, MTB-IGFIR/Akt1 -/- and MTB-IGFIR/Akt2 -/- mice. Immunohistochemistry for cytokeratin 8 (A-C), cytokeratin 5 (D-F) or cytokeratin 14 (G-I) in mammary tumors from MTB-IGFIR mice (A,D,G), MTB-IGFIR/Akt1−/− mice (B,E,H) or MTB-IGFIR/Akt2−/− mice (C,F,I). The brown color indicates the presence of each protein while the nuclei of the cells are blue due to hematoxylin staining. Scale bars, 100 μm.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us